Season's Savings | ₹5/mo for 3 months
₹199/month after first 3 months. Renews automatically. Terms apply.
RVMD Today - Aug 09: Demand Drives Price Up
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
Written by:
About this listen
Here’s the scoop. RVMD saw some nice movement today, and honestly, it’s been a rollercoaster lately. There’s been a lot of talk about their drug, Daraxonrasib, really picking up steam. Apparently, there’s a growing demand for it, which is definitely giving the stock a boost. I mean, after some tough losses recently, it’s like the market’s finally giving them a little love.
Now, let’s get into the why. Assenagon Asset Management jumped in and bought a hefty chunk of shares—over 200,000 of them. That’s a solid vote of confidence right there. Meanwhile, J.P. Morgan’s keeping the faith too, maintaining a buy rating and even raising their target price to $227. So, folks are clearly seeing potential here. On the flip side, Sei Investments decided to cut down their holdings, which is a bit of a mixed bag, but the overall vibe today was pretty positive.
One thing that’s worth mentioning is that the demand for Daraxonrasib seems to be a game-changer for them. As more buzz builds around it, it could really shake things up for RVMD in the coming months.
Alright, that’s the scoop for today! Just remember, this is all for your info and entertainment, not financial advice. Catch you later!
adbl_web_anon_alc_button_suppression_t1
No reviews yet